Financhill
Back

CASI Pharmaceuticals Quote, Financials, Valuation and Earnings

CASI Pharmaceuticals Price Quote

$5.25
-0.01 (-0.19%)
(Updated: November 21, 2024 at 5:55 PM ET)

CASI Pharmaceuticals Key Stats

Buy
52
CASI Pharmaceuticals (CASI) is a Buy

Day range:
$4.77 - $5.52
52-week range:
$2.05 - $8.48
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.54
P/B ratio:
6.28%

Volume:
62.7K
Avg. volume:
33.2K
1-year change:
1.15%
Market cap:
$86.9M
Revenue:
$33.9M
EPS:
$-2.24

How Much Does CASI Pharmaceuticals Make?

Is CASI Pharmaceuticals Growing As A Company?

  • What Is CASI Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.12%
  • What Is CASI Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

CASI Pharmaceuticals Stock Price Performance

What Is CASI Pharmaceuticals 52-Week High & Low?

CASI Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy CASI Pharmaceuticals?

Is CASI Pharmaceuticals Cash Flow Positive?

Data Unavailable

CASI Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    CASI return on invested capital is -82.29%
  • What Is CASI Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -47.99%
  • What Is CASI Return On Equity?
    ROE is a measure of profitability and is -137%

CASI Pharmaceuticals Earnings Date & Stock Price

CASI Pharmaceuticals Competitors

CASI Pharmaceuticals Dividend Yield

CASI Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -11.82% 70.9%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 6.00
Upside from Last Price: 14.07%

Major Shareholders

  • How many CASI shares are owned by institutional investors?
    2.5M CASI shares are owned by institutional investors
  • How many CASI shares are owned by insiders?
    1.9M CASI shares are owned by insiders